Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000897069-25-000664
Filing Date
2025-03-19
Accepted
2025-03-19 19:13:50
Documents
1
Period of Report
2025-03-10

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3572
  Complete submission text file 0000897069-25-000664.txt   5280
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Issuer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 867 COLUMBUS DRIVE TEANECK NJ 07666
Business Address
Tendler Craig (Reporting) CIK: 0002061924 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 25754123